|
 |
China Chemical Pharmaceutical Market Report, 2008
|
 
By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was CNY 122.467 billion and the total output value of chemical reagent was CNY 150.805 billion.
Total Output Value of China’s Chemical Pharmaceutical Industry, 2004-2008
Source: ResearchInChina
By the end of Sep, 2008, the total output of active pharmaceutical ingredient (API) in China was 1.675 million tons, of which, the output in Q12008 reached as many as 783,000 tons, up by 73.2% compared to Q1 2007.
API Output in China, 2005Q1-2008Q3
Source: ResearchInChina
This report gives an in-depth analysis of China’s chemical pharmaceutical industry, covering market segmentations, main products, and regional markets in China as well as the key players.
1. Overview of China Chemical Pharmaceutical Industry
1.1 Development Course
1.2 Classification of Chemical Pharmaceutical Companies
1.2.1 Reagent Manufacturers
1.2.2 Active Pharmaceutical Ingredient (API) Manufacturers
2. Overview of China Chemical Pharmaceutical Market
2.1 Overview of The Market
2.2 Characteristics of The Chemical Pharmaceutical Companies
3. China Active Pharmaceutical Ingredients (API) Market
3.1 Overview of the Market
3.2 Market Performance
3.2.1 Sales
3.2.2 Losses
3.3 API Import & Export
3.3.1 Export
3.3.2 Import
3.4 Competition Patterns
3.5 Market Performance of Major API Products
3.5.1 Cephalosporins
3.5.2 Vitamin C
3.5.3 Amoxycillin
3.5.4 Ceftriaxone Sodium
3.5.5 Clarithromycin
4. China Chemical Reagent Market
4.1 Overview of the Market
4.2 Market Performance
4.2.1 Sales
4.2.1 Losses
4.3 Import & Export
4.4 Market Performance of Major Reagent Products
4.4.1 Lipitor
4.4.2 Clopidogrel
4.4.3 Rituximab
4.4.4 Fluticasone/Salmeterol
4.4.5 Epoetin Alfa
4.4.6 Single Nitroglycerin
4.4.7 Isosorbide dinitrate
4.4.8 Nitroglycerin
5. Regional Chemical Pharmaceutical Markets in China
5.1 Overview
5.2 Shandong Province
5.2.1 Overview
5.2.2 Market Performance
5.2.3 Competition Patterns
5.3 Jiangsu Province
5.3.1 Overview
5.3.2 Market Performance
5.3.3 Competition Patterns
5.4 Zhejiang Province
5.4.1 Overview
5.4.2 Market Performance
5.4.3 Competition Patterns
5.5 Hebei Province
5.5.1 Overview
5.5.2 Market Performance
5.5.3 Competition Patterns
6. Analysis of Key Companies
6.1 Northeast Pharmaceutical Group Co., Ltd.
6.1.1 Company Profile
6.1.2 Operations
6.2 Hubei Biocause Pharmaceutical Co., Ltd.
6.2.1 Company Profile
6.2.2 Operations
6.3 Apeloa Co., Ltd.
6.3.1 Company Profile
6.3.2 Operations
6.4 Shandong Xinhua Pharmaceutical Co., Ltd.
6.4.1 Company Profile
6.4.2 Operations
6.5 Southwest Synthetic Pharmaceutical Co. Ltd.
6.5.1 Company Profile
6.5.2 Operations
6.6 Anhui Fengyuan Pharmaceutical Co., Ltd.
6.6.1 Company Profile
6.6.2 Operations
6.7 LIVZON Pharmaceutical Group Inc.
6.7.1 Company Profile
6.7.2 Operations
6.8 Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
6.8.1 Company Profile
6.8.2 Operations
6.9 Beijing Double-Crane Pharmaceutical Co., Ltd.
6.9.1 Company Profile
6.9.2 Operations
6.10 Hainan Haiyao Co., Ltd.
6.10.1 Company Profile
6.10.2 Operations
Total Output Value of China Chemical Pharmaceutical Industry, 2004-2008
Sales Revenue of China Chemical Pharmaceutical Industry, 2005-2008
The Proportion of Large and Medium-sized Chemical Pharmaceutical Companies in China in 2007
Assets of Chemical Pharmaceutical Companies in China by Size, Jan.-Nov.2007
Losses of Chemical Pharmaceutical Companies in China by Size, Jan.-Nov.2007
API Output in China, 2005Q1-2008Q3
Output Value of API in China, 2005-2008
Sales of API in China, 2005-2008
Sales / Output Ratio of API in China, 2005-2008
Accumulated Losses of API Manufacturers in China, 2006-2008
China API Export Value, 2005-2008
China API Import Value, 2005-2008
Sales Revenue and Assets of China Top Ten API Manufacturers, Sep.2008
Vitamin C Price in China, 2007-2008
Total Output Value of Chemical Reagent in China, 2006-2008
Sales of Chemical Reagent in China, 2006-2008
Sales / Output Ratio of Chemical Reagent in China, 2006-2008
The Number of Chemical Reagent Manufacturers in Loss, 2006-2008
Accumulated Losses of Chemical Reagent Manufacturers in China, 2006-2008
China Monthly Antibiotic Reagent Import, 2007-2008
Global Lipitor Sales, 2002-2008
Corresponding Proportion Taken by Nitrate Esters Medicines in 2007
Top Ten Provinces by Chemical Pharmaceutical Assets in China in 2007
Top Ten Provinces by Chemical Pharmaceutical Sales in China in 2007
Top Ten Provinces by Chemical Pharmaceutical Output in China in 2007
Regional Distribution of Chemical Pharmaceutical Companies in China, Jan.-Nov.2007
Gross Profit Margin of Chemical Pharmaceutical in Shandong Province, 2004-2007
Profits of API and Chemical Reagent in Shandong Province in 2007
Top Five API Manufacturers in Shandong Province in 2007
Top Five Chemical Reagent Manufacturers in Shandong Province in 2007
Gross Profit Margin of Chemical Pharmaceutical in Jiangsu Province, 2004-2007
Profits of API and Chemical Reagent in Jiangsu Province in 2007
Top Five API Manufacturers in Jiangsu Province in 2007
Top Five Chemical Reagent Manufacturers in Jiangsu Province in 2007
Gross Profit Margin of Chemical Pharmaceutical in Zhejiang Province, 2004-2007
Profits of API and Chemical Reagent in Zhejiang Province in 2007
Top Five API Manufacturers in Zhejiang Province in 2007
Top Five Chemical Reagent Manufacturers in Zhejiang Province in 2007
The Number of Chemical Pharmaceutical Companies in Hebei Province in 2007
Gross Profit Margin of Chemical Pharmaceutical in Hebei Province, 2004-2007
Profits of API and Chemical Reagent in Hebei Province in 2007
Top Five API Manufacturers in Hebei Province in 2007
Top Five Chemical Reagent Manufacturers in Hebei Province in 2007
Sales Revenue of Northeast Pharmaceutical Group Co., Ltd., 2001-2008
API Revenue of Northeast Pharmaceutical Group Co., Ltd., 2005-2008
Chemical Reagent Revenue of Northeast Pharmaceutical Group Co., Ltd., 2005-2008
Regional Sales Revenue of Northeast Pharmaceutical Group Co., Ltd, Jun.2008
Sales Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-Jun.2008
Production Capacity of Hubei Biocause Pharmaceutical Co., Ltd.
Regional Sales Revenue of Hubei Biocause Pharmaceutical Co., Ltd in 2008
API Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-2008
Chemical Reagent Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-2008
Sales Revenue of Apeloa Co., Ltd., 2003-2008
API Revenue of Apeloa Co., Ltd., 2003-2008
China Pharmaceutical Industry Statistics, 2000-2009 Thanks to the stimulus of new medical system reform launched by the government in 2009, the pharmaceuticals industry of China remains steady growth.
In the first half of 2009, the output of China’s c... China Antibiotic Market Report, 2008-2009 From the perspective of industrial scale, China's output and production capacity of antibiotic raw materials ranks the NO.1 in the world. In 2007, China's sales revenue of antibiotic raw materials rea... China Pharmaceutical Chain Industry Report, 2009 According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 b... China Vaccine Industry Report, 2008-2009 In the past decade, Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produ... US Pharmaceutical Industry Report, 2008-2009 The United States has the largest pharmaceutical industry in the world. In 2007, its pharmaceutical revenue totaled at US$ 315 billion.
Global Pharmaceutical Output Value and Profits by Region, 2007... Indian Pharmaceutical Formulations Industry Report, 2008-2009 India plays an important role in the global pharmaceutical market. In 2005, 2/5 DMFs to FDA were submitted by India. Currently, there are more than 400 kinds of API (Active Pharmaceutical Ingredient) ... Indian Active Pharmaceutical Ingredients(APIs) Industry Report, 2008-2009 India plays an important part in the global API market. The API output value of India was US $4.1 billion in 2007, with the CAGR as high as 18.81% during 2003-2007. And Indian ranks at the fourth in t... China Chemical Pharmaceutical Market Report, 2008 By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was C... China Vaccine Market Report, 2007-2009 China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 ton... China Pharmaceutical Chain Industry Report, 2007-2008 Pharmaceutical industry is called as "eternal sunrise industry", mainly because of its sustained growth in market demand. The main factors driving the growth in market demand of China's pharmaceutical... China Animal Vaccine Industry Report, 2006-2009 On Jan. 18th of 2008, Ministry of Agriculture of the People's Republic of China and Ministry of Health of China jointly issued the document to intensify the efforts to carry out the inoculation of rab... China Chemical Pharmaceutical Industry Report, 2007 Global medicine industry maintains rapid growth continuously.Its scale has started to maintain fast growth since the middle and late in the 20th century. The total output value increased to USD 602 bi... Company Study of Guangxi Wuzhou Zhongheng Group In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and... China OTC Drug Market Report, 2007 By 2003, the global OTC drug market had reached 63 billion, and China's OTC drugs shared 5.7% of the global market, only behind North America, West Europe and Japan. In 2003, the sales value in China'... China Pharmaceutical Industry Report, 2006-2007 In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier.
It is noteworthy that the sales of ch... China Anti-tumor Drugs Market Report, 2007 The anti-tumor drugs market operated well in 2006, and the total sales volume amounted to USD 34.6 billion, up 20.5% from a year earlier, and the growth margin ranked the first place among all the tre... Economic Operation of Pharmaceutical Industry in China, 2006 In 2006, total industrial output value of China pharmaceutical industry accumulated to RMB532.373 billion, up by 17.89% year on year. Total industrial output value of state-owned economy of pharmaceut... China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007 During the Tenth Five-Year Plan period (2001 to 2005), each indicator of the whole pharmaceutical industry greatly exceeded the scheduled; and the industrial output value, industrial added value and t...
|